Wang Yuji, Jiang Xueyun, Liu Jiawang, Zhao Ming, Kang Guifeng, Wu Jianhui, Peng Li, Peng Shiqi
College of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, PR China.
Mol Biosyst. 2011 May;7(5):1678-83. doi: 10.1039/c1mb05037k. Epub 2011 Mar 14.
Nitronyl nitroxides are capable of preventing cells, tissues, and organs from radical-induced damage through scavenging NO˙, ˙O(2)(-) and ˙OH. In order to explore the conversions of nitronyl nitroxides in biological systems with and without NO˙, HPLC-MS aided PC12 cell systems were developed, and the conversions of 2-(3'-nitrophenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl -3-oxide (3-nitro-PTIO), 1-oxyl-2-(3'-nitrophenyl)-4,4,5,5-tetramethylimidazoline (3-nitro-PTI), and 1-hydroxyl-2-(3'-nitrophenyl)-4,4,5,5-tetramethylimidazoline (3-nitro-PTIH) were quantitatively monitored. In these systems 3-nitro-PTIO and 3-nitro-PTI were time-dependently converted to 3-nitro-PTIH, while no conversion of 3-nitro-PTIH was detected. Free radical NO˙ donors (sodium nitroprusside, SNP) accelerated the conversions, but had no effect upon the conversion product. In the in vitro and in vivo assays the 3-nitro-PTIH treated cells and mice exhibited no toxic response.
硝酮氮氧化物能够通过清除一氧化氮自由基(NO˙)、超氧阴离子自由基(˙O(2)(-))和羟基自由基(˙OH)来防止细胞、组织和器官受到自由基诱导的损伤。为了探究硝酮氮氧化物在有或没有NO˙的生物体系中的转化情况,开发了高效液相色谱-质谱联用辅助的PC12细胞体系,并对2-(3'-硝基苯基)-4,4,5,5-四甲基咪唑啉-1-氧基-3-氧化物(3-硝基-PTIO)、1-氧基-2-(3'-硝基苯基)-4,4,5,5-四甲基咪唑啉(3-硝基-PTI)和1-羟基-2-(3'-硝基苯基)-4,4,5,5-四甲基咪唑啉(3-硝基-PTIH)的转化进行了定量监测。在这些体系中,3-硝基-PTIO和3-硝基-PTI会随时间转化为3-硝基-PTIH,而未检测到3-硝基-PTIH的转化。自由基NO˙供体(硝普钠,SNP)加速了这种转化,但对转化产物没有影响。在体外和体内试验中,用3-硝基-PTIH处理的细胞和小鼠均未表现出毒性反应。